VisMederi Holding

Improving human health

Vismederi Holding

Vismederi Holding is the company that holds a qualified share of the companies that are part of the VisMederi Group. The Group of Vismederi Holding operates in various business areas all related to Research and Innovation in the fields of Public Health, Life Sciences and Biotechnologies and is composed of VisMederi Srl, VisMederi Research Srl, VisMederi Life Sciences Srl, VisMederi Textyle Srl, VisMederi Pharma Srl, ETHS – Education and Training for Health Sciences Srl with single shareholder, Accurange Srl.

Vismederi Holding
0Mln €

Revenues

0

Employees 

0Paesi

Global Partnerships

Vismederi Holding: latest news

All the news of the group

Nov 05 2024

VisMederi Recognized Among Top 300 Fastest-Growing Companies of 2023 by Financial Times and Statista

VisMederi is pleased to announce its inclusion in the distinguished 2023 list of the 300 fastest-growing companies, published by the Financial Times...
Nov 04 2024

New Collaborative Research between VisMederi Group and GVGH on Enteric Fever Published in Frontiers in Immunology

VisMederi Group is pleased to announce the publication of our latest collaborative research with GlaxoSmithKline’s Vaccine Global Health Institute...
Oct 18 2024

New Publication: Advancing Vaccine Research with GVGH – A Novel Assay for Quantifying Anti-Vi IgG in Clinical Sera

VisMederi is pleased to announce the publishing of a collaborative study with GVGH (GSK Vaccines Institute for Global Health) that highlights a...
Oct 08 2024

The first workshop involving Trialect and the Vismederi Foundation is underway!

For those wishing to fully immerse themselves in the serological techniques required by regulatory agencies including the FDA, EMA, and PMD for the...
Sep 30 2024

VisMederi Foundation at the Bright-Night 2024

European Night of Female Researchers and Scientists in Tuscany is known as Bright Night. Whether geographic, historical, artistic, literary,...
Sep 27 2024

VisMederi will be present at the World Vaccine Congress Europe 2024 in Barcelona

VisMederi will be attending the World Vaccine Congress Europe 2024, taking place from October 28th to 31st at Fira de Barcelona, Montjuïc. The...
Sep 24 2024

Collaboration Agreement Signed Between Trialect Inc. USA and Fondazione VisMederi

Fondazione VisMederi has signed an agreement with Trialect Inc., USA, for the program entitled “Trialect Global Medical Education Program.” This...
Aug 23 2024

A new study suggests that antibodies produced by vaccinia-based vaccines may neutralize the Monkeypox virus

A new study suggests that antibodies produced by vaccinia-based vaccines may neutralize the Monkeypox virus, suggesting potential cross-protection...
Aug 07 2024

VisMederi has been successfully qualified by Qualifyze for conducting activities according to GCLP

VisMederi has been successfully qualified by Qualifyze for conducting activities according to GCLP (Good Clinical Laboratory Practices). Both our...
Jun 12 2024

Important international study in the field of Monkey Pox and Vaccinia Virus

Another important international study in the field of Monkey Pox and Vaccinia Virus: a sero-epidemiological study assessing the neutralizing...

Where we

are

 

 

 

 

 

 

The

founder

Emanuele Montomoli is Full Professor of Hygiene and Public Health at the University of Siena, Italy. He received his BSc and MSc in Life Sciences from the University of Siena, Italy in 1997 and he earned his MBiochem in 2001.